Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-48,569
Closed -$3.37M 807
2022
Q2
$3.37M Sell
48,569
-6,091
-11% -$452K 0.03% 284
2022
Q1
$4.2M Buy
54,660
+37
+0.1% +$2.66K 0.03% 286
2021
Q4
$4.18M Buy
54,623
+1,199
+2% +$88.1K 0.03% 290
2021
Q3
$3.94M Buy
+53,424
New +$4.01M 0.03% 274
2021
Q2
Sell
-20,875
Closed -$1.55M 850
2021
Q1
$1.55M Buy
20,875
+3,437
+20% +$261K 0.01% 402
2020
Q4
$1.27M Buy
17,438
+648
+4% +$45.7K 0.01% 401
2020
Q3
$1.12M Buy
+16,790
New +$1.06M 0.01% 382

Other funds holding HOLX

Scotia Capital's HOLX Position: Q3 2022 in Review

Scotia Capital sold out of Hologic (HOLX) in Q3 2022, closing a stake of 48,569 shares — an estimated $3.37M sold.

Scotia Capital first reported a position in HOLX in Q3 2020 and held it in 7 quarters. The position peaked at $4.2M in Q1 2022. 654 funds tracked by Wall St. Rank hold HOLX as of Q3 2022.

  • Scotia Capital reported no remaining Hologic position as of Q3 2022 after selling out during the quarter.
  • Scotia Capital sold 48,569 Hologic shares in Q3 2022, an estimated $3.37M.
  • Scotia Capital first reported a position in Hologic in Q3 2020 and held it in 7 quarters.
  • Scotia Capital's Hologic position peaked at $4.2M in Q1 2022.
  • 654 funds tracked by Wall St. Rank held Hologic as of Q3 2022.

Based on Scotia Capital's 13F filing for Q3 2022, filed 10 Nov 2022.